Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Petesicatib

Generic Name: Petesicatib

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₃F_₆N_₅O_₄S

CAS Number: 1252637-35-6

Unique Ingredient Identifier: A26QO95U37

Overview

Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).

Background

Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome

Phase 2

Completed

Posted: 2016/03/08

Sponsor:Hoffmann-La Roche

ID:NCT02701985

A Study to Investigate the Pharmacokinetics, Pharmacodynamic Effects, Safety and Tolerability of Repeated Dosing of RO5459072 in Volunteers With Celiac Disease

Phase 1

Completed

Posted: 2016/02/10

Sponsor:Hoffmann-La Roche

ID:NCT02679014

A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers

Phase 1

Completed

Posted: 2015/08/13

Sponsor:Hoffmann-La Roche

ID:NCT02521610

A Study of RG7625 in Healthy Volunteers

Phase 1

Completed

Posted: 2014/11/20

Sponsor:Hoffmann-La Roche

ID:NCT02295332

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy